To evaluate temporal trends in neoadjuvant chemotherapy (NAC) utilization and outcomes in patients with locally advanced upper tract urothelial carcinoma (UTUC).
We included 289 patients from seven hospitals who underwent radical nephroureterectomy (RNU) for locally advanced UTUC (≥cT3 or cN+) between 2000 and 2020.